Skip to main content
Toggle Menu of ADA WebSites
ADA Websites
Partnerships and Commissions
Toggle Member Links
Toggle Menu
e-mail Print Share
The Top 200 Prescription Drugs Part 3
CE Credit(s):
3
Member Price:
$147.00
Retail Price:
$207.00
Description
Open Tabs
Description:

Updated in 2018!

Introduce evidence-based knowledge essential for risk stratification and dental management of patients with endocrine disorders.

Learning Objectives:

  1. Discuss the medical management of patients with endocrine disorders predicated on the top 200 prescription drugs
  2. Discuss disease-related, treatment-related, and procedure-related variables
  3. Develop therapeutic strategies predicated on the patient’s ability to undergo and respond to dental care

Abstract:

Our primary obligation and ultimate reasonability is the timely delivery of quality diagnostic, preventive, and therapeutic services, within the bounds of the clinical circumstances presented by patients. Consequently, we must possess knowledge and skills essential to determine the functional state of patients to undergo and respond to dental care. Diagnostic activities should be validated and focused  not only on identifying those problems that one cannot afford to miss but also to identify those patients with an increased likelihood of developing a disease and those who may experience an increase in disease severity or a medical emergency in the perioperative period.

Outline:

  1. Introduction
  2. Endocrine agents in the Top 200 Drugs
    1. Mechanisms of action
    2. Clinical indications
    3. Adverse drug effects
  3. Endocrine disorders predicated on the Top 200 Drugs
  4. Risk stratification and dental management of patients
    1. Disease-specific risk factors
    2. Treatment-specific risk factors
    3. Procedure-specific risk factors
  5. Conclusion
Related Courses:

 

More from the ADA: